For people with aneurysmal subarachnoid hemorrhage and anemia, there was no significant neurological benefit from getting red ...

Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...

Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination ...

The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear.

Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...

Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...

Researchers have demonstrated that implementation of a liberal blood transfusion policy does not offer cognitive-neurological ...

PRINCETON, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: GRCE) formerly Acasti Pharma Inc. (Nasdaq: ACST) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a ...